Acerca de
Viz.ai’s mission is to improve access to life-saving treatments. Viz.ai builds AI Care Pathways to help every patient get the right care, at the right time. Co-founded out of Stanford in 2016, Viz.ai has achieved major AI industry milestones, including the first FDA clearance for AI, two FDA de novo approvals for AI computer-aided triage and cardiovascular machine-learning notification software, and 10 additional 510(k) clearances. Viz.ai was also the first AI company to receive CMS reimbursement through the New Technology Add-on Payment (NTAP) for AI. Today, Viz.ai is used in 2,000+ hospitals, serving 230M+ lives across neurology, cardiology, oncology, pulmonology and other disease areas.
